Literature DB >> 1446256

Perifusion system: its use in the study of the neuroendocrine control of human pituitary tumoral cells.

D Joubert1, A M Brandi, F Peillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1446256     DOI： 10.1007/bf00130509

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN： 0742-2091            Impact factor:   6.691


× No keyword cloud information.
  8 in total

1.  Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist.

Authors:  M C Gershengorn; M E Paul
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

2.  Receptors and neurohormones in human pituitary adenomas.

Authors:  F Peillon; M Le Dafniet; P Garnier; A M Brandi; E Moyse; P Birman; J Blumberg-Tick; D Grouselle; D Joubert-Bression
Journal:  Horm Res       Date:  1989

3.  Human pancreatic tumor growth hormone-releasing factor stimulates anterior pituitary adenylate cyclase activity, adenosine 3',5'-monophosphate accumulation, and growth hormone release in a calmodulin-dependent manner.

Authors:  G Schettini; M J Cronin; E L Hewlett; M O Thorner; R M MacLeod
Journal:  Endocrinology       Date:  1984-10       Impact factor: 4.736

4.  Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.

Authors:  D Bression; A M Brandi; A Nousbaum; M Le Dafniet; J Racadot; F Peillon
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

5.  Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.

Authors:  D Joubert; C Benlot; A Lagoguey; P Garnier; A M Brandi; J P Gautron; J C Legrand; F Peillon
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

6.  Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.

Authors:  M Le Dafniet; P Lefebvre; A Barret; C Mechain; M C Feinstein; A M Brandi; F Peillon
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

7.  Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.

Authors:  D Bression; A M Brandi; M P Martres; A Nousbaum; F Cesselin; J Racadot; F Peillon
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

8.  Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.

Authors:  M Le Dafniet; A M Brandi; D Bression; T Racadot; F Peillon
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.